Northern Trust Corp Raises Stake in SI-BONE, Inc. (NASDAQ:SIBN)

Northern Trust Corp lifted its holdings in shares of SI-BONE, Inc. (NASDAQ:SIBN - Free Report) by 6.3% in the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 409,122 shares of the company's stock after acquiring an additional 24,214 shares during the quarter. Northern Trust Corp owned approximately 0.98% of SI-BONE worth $5,736,000 as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Mainstream Capital Management LLC purchased a new position in shares of SI-BONE during the fourth quarter valued at about $53,000. R Squared Ltd purchased a new position in shares of SI-BONE in the 4th quarter valued at approximately $73,000. KLP Kapitalforvaltning AS purchased a new position in shares of SI-BONE in the 4th quarter valued at approximately $97,000. Proficio Capital Partners LLC bought a new stake in shares of SI-BONE during the fourth quarter valued at approximately $155,000. Finally, AlphaQuest LLC raised its holdings in SI-BONE by 13,950.6% in the fourth quarter. AlphaQuest LLC now owns 11,662 shares of the company's stock worth $164,000 after purchasing an additional 11,579 shares in the last quarter. Hedge funds and other institutional investors own 98.11% of the company's stock.

SI-BONE Stock Down 0.2%

SI-BONE stock traded down $0.04 during trading hours on Monday, hitting $18.38. The stock had a trading volume of 273,310 shares, compared to its average volume of 375,257. The stock's 50-day moving average price is $15.30 and its 200-day moving average price is $15.21. SI-BONE, Inc. has a 12-month low of $11.70 and a 12-month high of $20.05. The company has a quick ratio of 7.22, a current ratio of 8.25 and a debt-to-equity ratio of 0.22. The stock has a market capitalization of $783.26 million, a P/E ratio of -19.98 and a beta of 0.82.

SI-BONE (NASDAQ:SIBN - Get Free Report) last issued its earnings results on Monday, May 5th. The company reported ($0.15) EPS for the quarter, beating the consensus estimate of ($0.24) by $0.09. The business had revenue of $47.29 million for the quarter, compared to the consensus estimate of $45.13 million. SI-BONE had a negative return on equity of 22.51% and a negative net margin of 23.82%. Equities research analysts anticipate that SI-BONE, Inc. will post -0.78 EPS for the current fiscal year.

Analysts Set New Price Targets

A number of analysts have recently weighed in on SIBN shares. Needham & Company LLC reaffirmed a "buy" rating and issued a $24.00 target price on shares of SI-BONE in a research report on Tuesday, May 6th. Cantor Fitzgerald reiterated an "overweight" rating and set a $25.00 target price on shares of SI-BONE in a report on Tuesday, May 6th. Finally, Truist Financial boosted their price target on SI-BONE from $20.00 to $22.00 and gave the stock a "buy" rating in a research report on Tuesday, May 6th.

Insider Transactions at SI-BONE

In related news, SVP Michael A. Pisetsky sold 3,128 shares of SI-BONE stock in a transaction that occurred on Wednesday, April 2nd. The shares were sold at an average price of $14.14, for a total transaction of $44,229.92. Following the transaction, the senior vice president now directly owns 244,878 shares of the company's stock, valued at $3,462,574.92. This trade represents a 1.26% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through this link. Also, CFO Anshul Maheshwari sold 2,424 shares of SI-BONE stock in a transaction on Monday, May 19th. The shares were sold at an average price of $19.48, for a total value of $47,219.52. Following the completion of the transaction, the chief financial officer now owns 222,083 shares in the company, valued at $4,326,176.84. This represents a 1.08% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 92,565 shares of company stock valued at $1,669,871 over the last three months. Corporate insiders own 4.00% of the company's stock.

About SI-BONE

SI-BONE, Inc, a medical device company, that operate to solve musculoskeletal disorders of the sacropelvic anatomy in the United States and internationally. It offers proprietary minimally invasive surgical implant system to address sacroiliac joint dysfunction and fusion, adult deformity and degeneration, and pelvic trauma; and implantable bone products.